Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Colorectal Neoplasms

Free Subscription Articles published in Cancer Retrieve available abstracts of 57 articles: HTML format Text format

Single Articles

November 2018
1. ZHANG D, Matthews CE, Powell-Wiley TM, Xiao Q, et al
   Ten-year change in neighborhood socioeconomic status and colorectal cancer.
   Cancer. 2018 Nov 13. doi: 10.1002/cncr.31832.
   PubMed     Text format     Abstract available
   
   
   October 2018
2. LARA CL, Means KL, Morwood KD, Lighthall WR, et al
   Colorectal cancer screening interventions in 2 health care systems serving disadvantaged populations: Screening uptake and cost-effectiveness.
   Cancer. 2018 Oct 25. doi: 10.1002/cncr.31691.
   PubMed     Text format     Abstract available
   
   
   
3. TANGKA FKL, Subramanian S, DeGroff AS, Wong FL, et al
   Identifying optimal approaches to implement colorectal cancer screening through participation in a learning laboratory.
   Cancer. 2018 Oct 25. doi: 10.1002/cncr.31679.
   PubMed     Text format    
   
   
   
4. KIM KE, Randal F, Johnson M, Quinn M, et al
   Economic assessment of patient navigation to colonoscopy-based colorectal cancer screening in the real-world setting at the University of Chicago Medical Center.
   Cancer. 2018 Oct 25. doi: 10.1002/cncr.31690.
   PubMed     Text format     Abstract available
   
   
   
5. DACUS HLM, Wagner VL, Collins EA, Matson JM, et al
   Evaluation of patient-focused interventions to promote colorectal cancer screening among New York state Medicaid managed care patients.
   Cancer. 2018 Oct 25. doi: 10.1002/cncr.31692.
   PubMed     Text format     Abstract available
   
   
   
6. KEMPER KE, Glaze BL, Eastman CL, Waldron RC, et al
   Effectiveness and cost of multilayered colorectal cancer screening promotion interventions at federally qualified health centers in washington state.
   Cancer. 2018 Oct 25. doi: 10.1002/cncr.31693.
   PubMed     Text format     Abstract available
   
   
   
7. SUBRAMANIAN S, Hoover S, Tangka FKL, DeGroff A, et al
   A conceptual framework and metrics for evaluating multicomponent interventions to increase colorectal cancer screening within an organized screening program.
   Cancer. 2018 Oct 25. doi: 10.1002/cncr.31686.
   PubMed     Text format     Abstract available
   
   
   
8. CHU JN, Choi J, Ostvar S, Torchia JA, et al
   Cost-effectiveness of immune checkpoint inhibitors for microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer.
   Cancer. 2018 Oct 21. doi: 10.1002/cncr.31795.
   PubMed     Text format     Abstract available
   
   
   September 2018
9. 
   American Cancer Society updates its colorectal cancer screening guideline: New recommendation is to start screening at age 45 years.
   Cancer. 2018;124:3631-3632.
   PubMed     Text format    
   
   
   
10. CHANGOOR NR, Pak LM, Nguyen LL, Bleday R, et al
    Effect of an Equal-Access Military Health System on Racial Disparities in Colorectal Cancer Screening.
    Cancer. 2018 Sep 12. doi: 10.1002/cncr.31637.
    PubMed     Text format     Abstract available
    
    
    
11. 
    Erratum: Long Y, Sanchez-Espiridion B, Lin M, et al. Global and targeted serum metabolic profiling of colorectal cancer progression. Cancer. 2018;124: 785-796.
    Cancer. 2018;124:3621.
    PubMed     Text format    
    
    
    July 2018
12. PRINTZ C
    Declines in death from colorectal cancer in europe deemed major success.
    Cancer. 2018;124:2876.
    PubMed     Text format    
    
    
    June 2018
13. SANOFF HK, Goldberg RM, Ivanova A, O'Reilly S, et al
    Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancer.
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31552.
    PubMed     Text format     Abstract available
    
    
    May 2018
14. MEESTER RGS, Peterse EFP, Knudsen AB, de Weerdt AC, et al
    Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline.
    Cancer. 2018 May 30. doi: 10.1002/cncr.31542.
    PubMed     Text format     Abstract available
    
    
    
15. PETERSE EFP, Meester RGS, Siegel RL, Chen JC, et al
    The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline.
    Cancer. 2018 May 30. doi: 10.1002/cncr.31543.
    PubMed     Text format     Abstract available
    
    
    
16. KROENKE CH, Prado CM, Meyerhardt JA, Weltzien EK, et al
    Muscle radiodensity and mortality in patients with colorectal cancer.
    Cancer. 2018 May 24. doi: 10.1002/cncr.31405.
    PubMed     Text format     Abstract available
    
    
    April 2018
17. AZAR I, Esfandiarifard S, Sinai P, Mehdi S, et al
    Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009.
    Cancer. 2018 Apr 30. doi: 10.1002/cncr.31525.
    PubMed     Text format    
    
    
    
18. WHITE A, Rim SH, Joseph DA, Johnson CJ, et al
    Reply to Colon cancer survival in the US Department of Veterans Affairs by race and stage: 2001 through 2009.
    Cancer. 2018 Apr 30. doi: 10.1002/cncr.31523.
    PubMed     Text format    
    
    
    
19. KARUTURI MS, Holmes HM, Lei X, Johnson M, et al
    Potentially inappropriate medication use in older patients with breast and colorectal cancer.
    Cancer. 2018 Apr 24. doi: 10.1002/cncr.31403.
    PubMed     Text format     Abstract available
    
    
    
20. ALATISE OI, Ayandipo OO, Adeyeye A, Seier K, et al
    A symptom-based model to predict colorectal cancer in low-resource countries: Results from a prospective study of patients at high risk for colorectal cancer.
    Cancer. 2018 Apr 12. doi: 10.1002/cncr.31399.
    PubMed     Text format     Abstract available
    
    
    
21. MOLS F, Schoormans D, de Hingh I, Oerlemans S, et al
    Symptoms of anxiety and depression among colorectal cancer survivors from the population-based, longitudinal PROFILES Registry: Prevalence, predictors, and impact on quality of life.
    Cancer. 2018 Apr 6. doi: 10.1002/cncr.31369.
    PubMed     Text format     Abstract available
    
    
    
22. TSOH JY, Tong EK, Sy AU, Stewart SL, et al
    Knowledge of colorectal cancer screening guidelines and intention to obtain screening among nonadherent Filipino, Hmong, and Korean Americans.
    Cancer. 2018;124 Suppl 7:1560-1567.
    PubMed     Text format     Abstract available
    
    
    
23. CUARESMA CF, Sy AU, Nguyen TT, Ho RCS, et al
    Results of a lay health education intervention to increase colorectal cancer screening among Filipino Americans: A cluster randomized controlled trial.
    Cancer. 2018;124 Suppl 7:1535-1542.
    PubMed     Text format     Abstract available
    
    
    
24. SY AU, Lim E, Ka'opua LS, Kataoka-Yahiro M, et al
    Colorectal cancer screening prevalence and predictors among Asian American subgroups using Medical Expenditure Panel Survey National Data.
    Cancer. 2018;124 Suppl 7:1543-1551.
    PubMed     Text format     Abstract available
    
    
    
25. TRAN MT, Jeong MB, Nguyen VV, Sharp MT, et al
    Colorectal cancer beliefs, knowledge, and screening among Filipino, Hmong, and Korean Americans.
    Cancer. 2018;124 Suppl 7:1552-1559.
    PubMed     Text format     Abstract available
    
    
    
26. SUN A, Tsoh JY, Tong EK, Cheng J, et al
    A physician-initiated intervention to increase colorectal cancer screening in Chinese patients.
    Cancer. 2018;124 Suppl 7:1568-1575.
    PubMed     Text format     Abstract available
    
    
    March 2018
27. BLACK DS, Cole SW, Christodoulou G, Figueiredo JC, et al
    Genomic mechanisms of fatigue in survivors of colorectal cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31356.
    PubMed     Text format     Abstract available
    
    
    
28. POLITE BN, Cipriano-Steffens TM, Hlubocky FJ, Jean-Pierre P, et al
    Association of externalizing religious and spiritual beliefs on stage of colon cancer diagnosis among black and white multicenter urban patient populations.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31351.
    PubMed     Text format     Abstract available
    
    
    
29. PISHVAIAN MJ, Slack RS, Jiang W, He AR, et al
    A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer.
    Cancer. 2018 Mar 26. doi: 10.1002/cncr.31309.
    PubMed     Text format     Abstract available
    
    
    February 2018
30. EBERTH JM, Thibault A, Caldwell R, Josey MJ, et al
    A statewide program providing colorectal cancer screening to the uninsured of South Carolina.
    Cancer. 2018 Feb 7. doi: 10.1002/cncr.31250.
    PubMed     Text format     Abstract available
    
    
    January 2018
31. ROSS JS, Fakih M, Ali SM, Elvin JA, et al
    Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31125.
    PubMed     Text format     Abstract available
    
    
    
32. PRINTZ C
    Death rates for colorectal cancer rising for individuals aged younger than 55 years.
    Cancer. 2018;124:229.
    PubMed     Text format    
    
    
    
33. RILEY JM, Cross AW, Paulos CM, Rubinstein MP, et al
    The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.
    Cancer. 2018 Jan 9. doi: 10.1002/cncr.31214.
    PubMed     Text format     Abstract available
    
    
    
34. PRINTZ C
    Study finds link between inflammation and colorectal cancer.
    Cancer. 2018;124:13.
    PubMed     Text format    
    
    
    
35. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Text format     Abstract available
    
    
    December 2017
36. WHITE A, Joseph D, Rim SH, Johnson CJ, et al
    Colon cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5014-5036.
    PubMed     Text format     Abstract available
    
    
    
37. JOSEPH DA, Johnson CJ, White A, Wu M, et al
    Rectal cancer survival in the United States by race and stage, 2001 to 2009: Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5037-5058.
    PubMed     Text format     Abstract available
    
    
    
38. DOROUDI M, Schoen RE, Pinsky PF
    Early detection versus primary prevention in the PLCO flexible sigmoidoscopy screening trial: Which has the greatest impact on mortality?
    Cancer. 2017;123:4815-4822.
    PubMed     Text format     Abstract available
    
    
    
39. MEROPOL NJ, Feng Y, Grem JL, Mulcahy MF, et al
    Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203).
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.30967.
    PubMed     Text format     Abstract available
    
    
    
40. NIXON NA, Khan OF, Imam H, Tang PA, et al
    Drug development for breast, colorectal, and non-small cell lung cancers from 1979 to 2014.
    Cancer. 2017;123:4672-4679.
    PubMed     Text format     Abstract available
    
    
    November 2017
41. TRICOLI JV, Boardman LA, Patidar R, Sindiri S, et al
    A mutational comparison of adult and adolescent and young adult (AYA) colon cancer.
    Cancer. 2017 Nov 30. doi: 10.1002/cncr.31136.
    PubMed     Text format     Abstract available
    
    
    
42. SARMA EA, Kawachi I, Poole EM, Tworoger SS, et al
    Social integration and survival after diagnosis of colorectal cancer.
    Cancer. 2017 Nov 21. doi: 10.1002/cncr.31117.
    PubMed     Text format     Abstract available
    
    
    
43. ZHAO H, Zhang N, Ho V, Ding M, et al
    Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011.
    Cancer. 2017 Nov 15. doi: 10.1002/cncr.31094.
    PubMed     Text format     Abstract available
    
    
    
44. CASSIDY RJ, Switchenko JM, Cheng E, Jiang R, et al
    Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer.
    Cancer. 2017;123:4325-4336.
    PubMed     Text format     Abstract available
    
    
    
45. ZHANG J, Raju GS, Chang DW, Lin SH, et al
    Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31062.
    PubMed     Text format     Abstract available
    
    
    October 2017
46. PRINTZ C
    Some stage III colon cancer patients may need only half of the standard chemotherapy course.
    Cancer. 2017;123:3871.
    PubMed     Text format    
    
    
    
47. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    PubMed     Text format     Abstract available
    
    
    
48. LEVI Z, Kark JD, Katz LH, Twig G, et al
    Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study.
    Cancer. 2017;123:4022-4030.
    PubMed     Text format     Abstract available
    
    
    
49. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Text format     Abstract available
    
    
    
50. SEGNAN N, Armaroli P
    Early detection versus prevention in colorectal cancer screening: Methods estimates and public health implications.
    Cancer. 2017 Oct 4. doi: 10.1002/cncr.31032.
    PubMed     Text format    
    
    
    
51. HONG YR, Tauscher J, Cardel M
    Distrust in health care and cultural factors are associated with uptake of colorectal cancer screening in Hispanic and Asian Americans.
    Cancer. 2017 Oct 4. doi: 10.1002/cncr.31052.
    PubMed     Text format     Abstract available
    
    
    September 2017
52. DESHMUKH AA, Chiao EY, Cantor SB, Stier EA, et al
    Management of precancerous anal intraepithelial lesions in human immunodeficiency virus-positive men who have sex with men: Clinical effectiveness and cost-effectiveness.
    Cancer. 2017 Sep 26. doi: 10.1002/cncr.31035.
    PubMed     Text format     Abstract available
    
    
    
53. SADETZKI S, Chetrit A, Freedman LS, Hakak N, et al
    Cancer risk among Holocaust survivors in Israel-A nationwide study.
    Cancer. 2017;123:3335-3345.
    PubMed     Text format     Abstract available
    
    
    August 2017
54. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    PubMed     Text format     Abstract available
    
    
    
55. JAGAI JS, Messer LC, Rappazzo KM, Gray CL, et al
    County-level cumulative environmental quality associated with cancer incidence.
    Cancer. 2017;123:2901-2908.
    PubMed     Text format     Abstract available
    
    
    
56. MALAPELLE U, Mayo-de-Las-Casas C, Molina-Vila MA, Rosell R, et al
    Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens.
    Cancer. 2017;125:615-626.
    PubMed     Text format     Abstract available
    
    
    December 2016
57. GULATI R, Albertsen PC
    Insights from the PLCO trial about prostate cancer screening.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: